Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in Long Term After Stopping Imatinib

NCT01343173 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT01343173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01343173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in Long Term After Stopping Imatinib
Lead sponsor
University Hospital, Bordeaux
Phase
Not applicable
Overall status
Completed
Start date
April 6, 2011
Completion date
May 30, 2017
Enrollment
220 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukaemia